• Article highlight
  • Article tables
  • Article images

Article History

Received : 17-07-2022

Accepted : 10-09-2022



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 682

PDF Downloaded: 247


Get Permission Patel, Patel, Patel, Patel, Kotecha, and Mendpara: The comparative efficacy of two different doses of fentanyl on hemodynamic response to laryngoscopy and tracheal intubation: Prospective, randomized control trail


Introduction

Laryngoscopy and tracheal intubation is an intense, noxious stimulation which is associated with hemodynamic changes due to reflex autonomic discharge.1 There is a necessity to blunt this response to prevent deleterious effects like arrhythmias, myocardial ischemia, increased intracranial pressure, rupture of cerebral aneurysm etc.2 Various drugs like intravenous lidocaine, adrenergic blocking drugs like alpha blockers and beta blockers, vasodilators like nitroprusside, nitroglycerin, hydralazine and intravenous opioids are used for attenuation of hemodynamic response to laryngoscopy and tracheal intubation. Various studies have already discovered that fentanyl 2mcg/kg is effective in attenuating this cardiovascular responses.2, 3, 4, 5, 6, 7 However, in this studies thiopentone3 and propofol6 are used as induction agents. Very few studies have been carried out to determine the ideal dose of fentanyl for attenuation of this hemodynamic response with etomidate as an induction agent.5, 8

Etomidate is a rapidly acting anaesthetic induction agent. It appears to produce hypnosis, amnesia, and inhibition of nociceptive responses, almost exclusively via actions at one class of neuronal ion channels (i.e. γ-aminobutyric acid type A receptors [GABAA receptors].9, 10 It has a very favourable hemodynamic profile on induction, no change in myocardial contractility and cardiac output.11 But is having some annoying side effects in the form of pain on injection, myoclonus and postoperative nausea and vomiting apart from suppression of adrenal synthesis.9, 12 It does not have any analgesic effect. Therefore, etomidate by itself, even in large doses, produces relatively light anaesthesia for laryngoscopy. Thus marked increases in heart rate and blood pressure may be found when Etomidate is solely used for induction.13 Pre-treatment with fentanyl can attenuate these side effects during induction with etomidate and also blunt the hemodynamic response to laryngoscopy and endotracheal intubation.9, 10

Fentanyl is a potent, synthetic opioid agonist with analgesic effect having rapid onset and short duration of action.14, 15, 16 As fentanyl in lower doses is associated with suboptimal attenuation of hemodynamic response and in higher doses is associated with systemic side effects like nausea, vomiting, sedation, pruritus, urinary retention, wooden chest syndrome and respiratory depression14, 15, 16 this study thus aims to compare two different doses of fentanyl (2.5 mcg/kg and 5 mcg/kg) to attenuate the hemodynamic response to laryngoscopy and endotracheal intubation in patients undergoing elective surgeries with etomidate as induction agent. Primary objective of the study is to compare attenuation of hemodynamic response of rise in heart rate, mean arterial pressure and rate pressure product of the two groups. While secondary objective is to compare intraoperative complications in the form of pain on injection, myoclonus, apnea, hypotension, bradycardia and tachycardia.

Materials and Methods

The study was carried out during the period of 2020-2021. It was a prospective randomized control trial approved by the Institutional Ethical Committee for Human Research-PG Research (IECHR-PGR).

From the reference study3 the effect size counted was 0.20 (medium effect), to achieve a power of greater than 80% with α value less than 0.05 (2-sided). A sample size of 60 (30 in each group) was required for to estimate difference of improvement in RPP between two groups as 1355 with standard deviation 1750 (using Med calc statistical software version 20.113).

Patients posted for elective surgery under general anaesthesia expected to last for more than one hour, belonging to American Society of Anaesthesiologists physical status I, II & and III and aged between 20 to 60 years of either sex were included in the study. Patients who refused to give consent, patients having anticipated difficult airway, patients having severe uncontrolled cardiovascular disease, respiratory disease, hepatic disease, central nervous system disease or renal disease that is constant threat to life of the patient and patients having allergy or hypersensitivity to study drug and pregnant or lactating females were excluded from the study.

Detailed preoperative assessment was performed on the previous day of surgery including history taking, general examination, systemic examination, airway assessment. All routine investigations were done. Patients were thoroughly counselled during the preoperative evaluation and were properly explained about the anaesthetic procedure and written informed consent was taken. Patients were kept nil by mouth from 10 p.m. previous night. Tab.Ranitidine 150mg and Tab Diazepam 10 mg orally were given on the previous night of surgery.

Anaesthesia machine, anaesthetic drugs, airway equipments including difficult airway cart, suction apparatus, multipara monitor, and all resuscitation drugs were checked and kept ready. Multipara monitor was attached. Baseline pulse rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, rate pressure product (RPP), arterial oxygen saturation were recorded (Tawake). Intravenous line was taken with 18G cannula in a large forearm vein and secured.

Randomization was done by the sealed envelope method.

Patients were grouped into following two groups.

Group F2.5: INJ fentanyl 2.5mcg/kg IV + INJ etomidate 0.3mg/kg IV.

Group F5: INJ fentanyl 5 mcg/kg IV + INJ etomidate0.3mg/kg IV.

Maintenance fluid ringer lactate was started 2 hrs before surgery according to weight of patients.

All the patients were premedicated with Injection Glycopyrrolate 5mc/kg IV, Injection Ondansetron 0.08mg/kg IV and Injection Paracetamol 100 mg IV infusion. Preoxygenation with 100% O2 was started. Priming dose of Injection Vecuronium i.e. 0.015mg/kg IV was given followed by Injection Fentanyl 2.5mcg/kg or 5mcg/kg over 30 seconds according to group allocation. After 3 minutes of preoxygenation induction with Injection Etomidate 0.3mg/kg over 30 seconds was done. Intubating dose of Injection vecuronium i.e. 0.085mg/kg was given. After 2 minutes of ventilation with 100% o2 and 2% Sevoflurane laryngoscopy and tracheal intubation was performed.

All patients who required the second attempt at intubation were excluded from the study.

Procedures like positioning, epinephrine infiltration, throat packing, Ryle’ tube insertion, urinary catheterization and surgery that might produce hemodynamic response and might interfere with study findings were withheld until the completion of 10 minutes post intubation period.

Anesthesia was maintained with controlled ventilation through close circuit with soda lime with O2:N2O (40:60) in a fresh gas flow of 6L/min, sevoflurane dial concentration 2%. Intermittently vecuronium 0.015mg/kg was given for muscle relaxation. Till 10 min of study duration, fresh gas flow and dial concentration of sevoflurane were not changed and there were not any surgical stimulus. After 10 minutes, fresh gas flow was reduced to 3L/min and sevoflurane was titrated according to hemodynamic response.

Heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure (diastolic pressure+1/3pulse pressure), rate pressure product and arterial oxygen saturation were recorded when patient was awake (Tawake), 3 minutes after giving Injection Fentanyl (T3), 1 minute after intubating dose of vecuronium T0 (asleep baseline), at the time of tracheal intubation (Ti), 1 minute, 3 minutes, 5 minutes and 10 minutes after tracheal intubation.

Patients were monitored for complications in the form of pain in injection, myoclonus, chest wall rigidity, respiratory depression, hypotension, bradycardia.

At the end of operation, Nitrous oxide and sevoflurane were stopped. Once the respiratory efforts were observed, the residual neuromuscular blockade was reversed by- IV Inj Neostigmine-50mcg/kg IV and Inj Glycopyrrolate-10mcg/kg.

Patients were extubated once all the criteria for extubation were met. Patients were shifted to recovery room.

Post operative complications in the form of nausea, vomiting and respiratory depression if any were noted.

Observations and Result

Out of 69 tested for eligibility, total 60 patients were enrolled in the study.

Both groups were comparable with respect to age, weight, sex, mean awake pulse rate, blood pressure, mean arterial pressure and rate pressure product.

Table 1

Comparison of patient characteristics in two groups

Demographic Data

Group F2.5

Group F5

P value

Patients

30

30

Age (yr), mean (SD)

50±6.984

53±9.743

0.1757

Sex (F/M)

16/14

15/15

Weight (kg), mean (SD)

62±3.956

63±5.426

0.4180

Height (cm), mean (SD)

163±9

164±8

0.723

ASA I/II/III

12/15/3

14/11/5

Heart Rate (per minute) (mean±SD)

86±8.56

83±6.15

0.12

Systolic BP (mm of Hg) (mean±SD)

128±7.43

129±7.15

0.59

Diastolic BP (mm of Hg) (mean±SD)

80±5.32

82±5.236

0.15

MAP (mm of Hg) (mean±SD)

96.16±4.76

98±5.19

0.15

RPP (mean±SD)

11043±1280

10639±936

0.16

SPO2(%) (mean±SD)

99±0.50

99±0.51

1.00

On intragroup comparison, in both the groups, there was no rise in pulse rate from baseline throughout the study period. On comparing both the groups, heart rate remained significantly less in Group F5 (p<0.01) as compared to Group F2.5 throughout the study period.

Table 2

Comparison of mean heart rate; HR: Heart rate

Time

Group F2.5

GroupF5

Intergroup p value

HR (/minute)

Intragroup P value

HR (/minute)

Intragroup P value

T0*

84±8.992

77±6.807

<0.0001

Ti **

84±8.059

1.000

78±6.886

0.573

<0.0001

T1

86±8.373

0.376

78±7.111

0.580

<0.0001

T3

85±8.152

0.653

78±6.590

0.565

<0.0001

T5

85±7.910

0.649

74±6.866

0.094

<0.0001

T10

84±8.035

1.000

73±7.820

0.038

<0.0001

[i] *(Asleep baseline i.e. 1 minute after full dose of vecuronium), **(At the time of tracheal intubation), T1, T3, T5, T10-1, 3, 5, and 10 minutes after tracheal intubation.

Heart rate remained significantly less in Group F5 as compared to Group F2.5 throughout the study period and in both the groups there was no rise in heart rate from baseline after laryngoscopy and tracheal intubation. In Group F5 there was statistically significant fall in pulse rate at 10 minutes after intubation but did not required pharmacological intervention.

Table 3

Comparison of mean arterial pressure. MAP: Mean arterial pressure

Time

Group F2.5

GroupF5

Intergroup p value

MAP (mm of Hg)

Intragroup P value

MAP (mm of Hg)

Intragroup P value

T0*

89.978±5.217

83±4.578

<0.0001

Ti **

90.611±4.959

0.6318

83±4.535

1.000

<0.0001

T1

94.267±4.909

0.0018

83±4.421

1.000

<0.0001

T3

90.778±4.761

0.5374

82±4.3608

0.3899

<0.0001

T5

90.378±4.478

0.7511

79±3.785

0.0005

<0.0001

T10

89.056±4.872

0.4820

78±3.631

<0.0001

<0.0001

[i] *(Asleep baseline i.e. 1 minute after full dose of vecuronium), **(At the time of tracheal intubation), T1, T3, T5, T10-1, 3, 5, and 10 minutes after tracheal intubation.

Mean arterial pressure (MAP) (Systolic pressure +1/3 Pulse Pressure) remained significantly less in Group F5 as compared to Group F2.5 throughout the study period. In group F2.5 their was statistically significant rise of MAP at one minute after tracheal intubation. However, their MAP was comparable to baseline at intubation, 3minutes, 5minutes and 10 minutes after intubation in both the groups. In Group F5 there was statistically significant fall in MAP at 5 and 10 minutes after intubation but did not required pharmacological intervention.

Table 4

Comparison of rate pressure product. RPP: Rate pressure product

Time

Group F2.5

Group F5

Intergroup p value

RPP (bpm*mmHg)

Intragroup P value

RPP (bpm* mmHg)

Intragroup P value

T0*

10021±1206

8096±896.135

<0.0001

Ti **

10073±1126.057

0.8636

8052±847.936

0.8458

<0.0001

T1

10571±1094.772

0.0695

8128±814.021

0.8854

<0.0001

T3

10139±1037.942

0.6861

7969±698.945

0.5409

<0.0001

T5

10094±987.104

0.7984

7545±714.021

0.0108

<0.0001

T10

9981±1109.117

0.8941

7359±828.0222

0.0016

<0.0001

[i] *(Asleep baseline i.e. 1 minute after full dose of vecuronium), **(At the time of tracheal intubation), T1, T3, T5, T10-1, 3, 5, and 10 minutes after tracheal intubation.

Rate pressure product (RPP) is very reliable indicator of myocardial oxygen demand. It is the product of heart rate (HR) and systolic blood pressure (SBP).17 Rate pressure product (RPP) remained significantly less in Group F5 as compared to Group F2.5 throughout the study period and in both the groups there was no rise in RPP from baseline after laryngoscopy and tracheal intubation.

In both the groups, none of the patient suffered from pain on injection, myoclonus and respiratory depression. The incidence of nausea, vomiting and hypotension was significantly higher in group F5 as compared to group F2.5.

Data analysis

Data were collected clinically and from multipara monitor. Qualitative data were analysed by Chi-square test. Quantitative data were presented as mean+standard deviation (SD) and they were analysed by students “t” test using med calc software(Version 20.113).

Discussion

Fentanyl, a potent rapid-acting synthetic opioid was first synthesized more than 50 years ago and has become the most commonly used opioid for attenuation of hemodynamic changes to laryngoscopy and tracheal intubation since then.18 The dose of fentanyl for complete sympathoadrenal blockade is greater than 7 mcg/kg.19 The studies done by Vinod Hosalli et al,3 Sidharth et al20 and Babita Bhupendra Singh et al6 concluded that fentanyl 2mcg/kg was as effective in attenuating hemodynamic response to laryngoscopy and tracheal intubation when compared with fentanyl 5mc/kg, lignocaine 1.5mc/kg along with fentanyl 2mcg/kg and labetalol 0.25 mc/kg respectively. However, they used thiopentone as an induction agent. Yukari et al7 with target controlled infusion of propofol discovered that fentanyl 2 mcg/kg in patients without hypertension and 4 mcg/kg in those with hypertension are preferable in order to minimize the changes in vital signs and cardiac output associated with tracheal intubation.

The study Byung et al.5 concluded that there was an increases in SBP and HR of more than 30% of the baseline levels when fentanyl 1.0 µg/kg (n = 30) with continuous infusion of 0.1 µg/kg/min was given 1 min before induction with etomidate 0.2 mg/kg. Thus their was need for further evaluation of ideal dose of fentanyl with etomidate as an induction agent.

S Vijayaragavan et al8 concluded that fentanyl 5 µg/kg pretreatment reduces the incidence of increases in heart rate and blood pressure, myoclonus and pain on injection during the induction-intubation sequence in ASA class I and II patients by monitoring heart rate, systemic blood pressure at 3 min after administration of fentanyl, 2 min after administration of etomidate, and 1min after intubation.16 The trend of hemodynamic fluctuation may not be precisely interpreted with monitoring only 1 time point after intubation, particularly the gap between the drop before intubation and the rise after intubation. Patients could be harmed from the hemodynamic differences. Also, larger doses of fentanyl may produce muscle rigidity. Priming with rocuronium or vecuronium reduced the incidence of difficult ventilation by avoiding the muscle rigidity.21

Figure 1

T0: Baseline parameters after full dose of injection vecuronium; Ti : At intubation; T1, T3, T5 and T10 1, 3, 5 and 10 minutes after intubation

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/4718709b-604e-4a80-8dc3-63d9a548943fimage1.png

In the present study fentanyl 2.5mcg/kg proved to be as effective as fentanyl 5mcg/kg in attenuation of pulse rate response following laryngoscopy and tracheal intubation, however fentanyl 5mcg/kg in more effective in attenuation of blood pressure response one minute after tracheal intubation. Fentanyl 2.5mcg/kg is as effective as fentanyl 5mc/kg in attenuation of blood pressure response at 3, 5 and 10 minutes post intubation. Mean Rate Pressure Product remained significant lower in fentanyl 5mcg/kg group. Hence, higher dose of fentanyl is required for attenuation of hemodynamic response to laryngoscopy and tracheal intubation despite the use of cardiostable drugs i.e. etomidate and vecuronium. The incidence of postoperative nausea and vomiting was higher in fentanyl 5mcg/kg group.

There are limitations in this study. First, the accuracy of actual BP readings might be vary owing to the improper size of BP cuff and patient mobilisation since noninvasive blood pressure measurement was applied. Moreover, the exact BP value might be lost at the time of intubation due to the delay measurement of non-continuous noninvasive BP cuff.

Second, patients with well-controlled hypertension and poorly controlled hypertension were included hence it may affect the magnitude of hemodynamic changes. The discrepancy of fasting duration may affect the preoperative fluid status and further infuence the hemodynamic parameters.

Conclusion

We conclude that Fentanyl Citrate in both the doses are equally effective in attenuating the heart rate response and 5mcg/kg is more effective in attenuating blood pressor response only 1 minute after tracheal intubation in ASA I, II and III patients. Both the doses are equally effective in attenuating blood pressure response at the time of intubation, 3min,5 min and 10 min after tracheal intubation. Rate Pressure Product remains lower in fentanyl 5mcg/kg.

Source of Funding

Nil.

Conflict of Interest

None.

Acknowledgements

We want to acknowledge Dr. Jayesh C Vasava, Head of Department, Department of Anesthesia, SSG hospital, Vadodara, for his constant support and DR. Swati Bhatt, Professor, Department of Anaesthesia, SSG hospital, Vadodara, for her help and guidance.

References

1 

IR Thomson The haemodynamic response to intubation: a perspectiveCan J Anaesth19893643679

2 

CY Teong CC Huang FJ Sun The Haemodynamic Response to Endotracheal Intubation at Different Time of Fentanyl Given During Induction: A Randomised Controlled Trial Sci Rep20201010.1038/s41598-020-65711-9

3 

V Hosalli A Es SY Hulkund C Joshi Comparative efficacy of different doses of fentanyl on cardiovascular responses to laryngoscopy and tracheal intubationJ Clin Diagn Res201489GC01GC03

4 

V Iyer WJ Russell Induction using fentanyl to suppress the intubation response in the cardiac patient: what is the optimal dose?Anaesth Intensive Care19881644117

5 

BJ Ko JN Oh JH Lee SR Choi SC Lee CJ Chung Comparison of effects of fentanyl and remifentanil on hemodynamic response to endotracheal intubation and myoclonus in elderly patients with etomidate inductionKorean J Anesthesiol2013641128PMCID

6 

Babita B Singh A Saiyed R Meena I Verma CK Vyas A comparative study of labetalol and fentanyl on the sympathomimetic response to laryngoscopy and intubation in vascular surgeriesKarnataka Anaesth J201512648

7 

Y Sawano M Miyazaki H Shimada Y Kadoi Optimal fentanyl dosage for attenuating systemic hemodynamic changes, hormone release and cardiac output changes during the induction of anesthesia in patients with and without hypertension: a prospective, randomized, double-blinded studyJ Anesth201327450511

8 

S Vijayaragavan M Balamurugan K Vasanth Comparison of Different Doses of Fentanyl for Attenuating Stress Response and Side Effects of Etomidate during Induction and Intubation: A Randomized Control StudyInt J Sci Study20171001100

9 

RJ Stockham TH Stanley NL Pace K King F Groen ST Gillmor Induction of anesthesia with fentanyl or fentanyl plus etomidate in high-risk patientsJ Cardiothorac Anesth1987111923

10 

A Holdcroft M Morgan JG Whitwam J Lumley Effect of dose and premedication on induction complications with etomidateBr J Anaesth1976483199205

11 

C Dumps D Bolkenius E Halbeck Etomidate for intravenous induction of anaesthesiaAnaesthesist2017661296980

12 

V Schuermans J Dom J Dony H Scheijgrond J Brugmans Multinational evaluation of etomidate for anesthesia induction. Conclusions and consequencesAnaesthesist1978272529

13 

JL Giese TH Stanley Etomidate: a new intravenous anesthetic induction agentPharmacotherapy1983352518

14 

VJ Collins Principles of Anesthesiology: General and Regional Anesthesia3rd edLea & FebigerPhiladelphia1993

15 

J Edmonds-Seal C Prys-Roberts Pharmacology of drugs used in neuroleptanalgesiaBr J Anaesth197042320716

16 

BB Misfeldt PB Jörgensen H Spotoft F Ronde The effects of droperidol and fentanyl on intracranial pressure and cerebral perfusion pressure in neurosurgical patientsBr J Anaesth197648109638

17 

M Ansari H Javadi M Pourbehi M Mogharrabi M Rayzan S Semnani The association of rate pressure product (RPP) and myocardial perfusion imaging (MPI) findings: a preliminary studyPerfusion201227320712

18 

TH Stanley The fentanyl storyJ Pain20141512121526

19 

A Evers M Maze Anesthetic Pharmacology: Basic Principles and Clinical Practice2nd edCambridge University PressCambridge201110.1017/CBO9780511781933

20 

SS Routray K Raut K Pradhan D Biswal D Mishra A Comparative Study of Fentanyl and Fentanyl Plus Lidocaine on Attenuation of Haemodynamic Stress Response to Laryngoscopy and Tracheal Intubation in Hypertensive PatientsInt J Res Health Sci201424100913

21 

J Nakada M Nishira R Hosoda K Funaki S Takahashi Priming with rocuronium or vecuronium prevents remifentanil-mediated muscle rigidity and difficult ventilationJ Anesth20192333238



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.